| Literature DB >> 21791575 |
Van A Doze1, Robert S Papay, Brianna L Goldenstein, Manveen K Gupta, Katie M Collette, Brian W Nelson, Mariaha J Lyons, Bethany A Davis, Elizabeth J Luger, Sarah G Wood, James R Haselton, Paul C Simpson, Dianne M Perez.
Abstract
The role of α(1)-adrenergic receptors (α(1)ARs) in cognition and mood is controversial, probably as a result of past use of nonselective agents. α(1A)AR activation was recently shown to increase neurogenesis, which is linked to cognition and mood. We studied the effects of long-term α(1A)AR stimulation using transgenic mice engineered to express a constitutively active mutant (CAM) form of the α(1A)AR. CAM-α(1A)AR mice showed enhancements in several behavioral models of learning and memory. In contrast, mice that have the α(1A)AR gene knocked out displayed poor cognitive function. Hippocampal brain slices from CAM-α(1A)AR mice demonstrated increased basal synaptic transmission, paired-pulse facilitation, and long-term potentiation compared with wild-type (WT) mice. WT mice treated with the α(1A)AR-selective agonist cirazoline also showed enhanced cognitive functions. In addition, CAM-α(1A)AR mice exhibited antidepressant and less anxious phenotypes in several behavioral tests compared with WT mice. Furthermore, the lifespan of CAM-α(1A)AR mice was 10% longer than that of WT mice. Our results suggest that long-term α(1A)AR stimulation improves synaptic plasticity, cognitive function, mood, and longevity. This may afford a potential therapeutic target for counteracting the decline in cognitive function and mood associated with aging and neurological disorders.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21791575 PMCID: PMC3187532 DOI: 10.1124/mol.111.073734
Source DB: PubMed Journal: Mol Pharmacol ISSN: 0026-895X Impact factor: 4.436